Anonymous ID: d96317 Feb. 24, 2023, 7:02 p.m. No.18406571   🗄️.is 🔗kun   >>6574 >>6584 >>6760 >>6899 >>7039 >>7152 >>7241 >>7263

A petition to stop FDA misleading doctors about covid-19 vaccines

 

https://maryannedemasi.substack.com/p/a-petition-to-stop-fda-misleading

 

Experts warn that the FDA is misleading doctors about the safety and efficacy of covid-19 vaccines, denying people the right to informed consent.

 

American clinicians typically call the folded-up piece of paper inside drug packaging the ‘package insert.’ Others call it the product label.

 

By law, the notoriously long, fine print prescribing information should contain accurate information about the safety and efficacy of the product.

 

But the existing product labels for the Pfizer and Moderna mRNA covid vaccines are out of date and omit important information, according to a group of nine experts belonging to the Coalition Advocating for Adequately Labeled Medicines (CAALM).

 

CAALM recently submitted a formal petition to the FDA asking for the labels on Pfizer and Moderna mRNA vaccines to be updated.

 

Linda Wastila, professor at the University of Maryland School of Pharmacy and CAALM member says, “If prescribers do not have the most current labelling information, how can they in good faith recommend to a patient that they should get the injection?”

 

“One of the big problems of the vaccine roll-out has been the lack of informed consent. Millions of people got the injection and have no clue about many aspects of the vaccine,” says Wastila.

 

If doctors are curious about a specific adverse event, they might look up the FDA or CDC website and conclude there's nothing to be concerned about.

 

But Wastila says, “By law, the product label must be accurate so having current information on the label is crucial. Part of the reason why people talk about myocarditis is because it’s on the label - it gives it legitimacy."

 

The 23-page document is compelling.

 

It meticulously outlines the rationale for each of ten requested efficacy and safety updates, and asks that the FDA communicates these changes via “Dear Health Care Provider” letters.

 

Wastila says, “In the document, we use the government’s and the manufacturer’s own words and data to show how misleading the public messages have been. It’s eye-opening.”

 

Other signatories on the petition include Peter Doshi, associate professor at the University of Maryland School of Pharmacy, Caleb Alexander, professor at Johns Hopkins Bloomberg School of Public Health, Vinay Prasad, haematologist-oncologist at the University of California San Francisco, Kim Witczak, leading international drug safety advocate, Marty Makary, public policy researcher at Johns Hopkins University, and Tianjing Li, associate professor at the University of Colorado Anschutz Medical Campus.

 

Updates on efficacy

The experts state that there is a widespread (but inaccurate) belief that vaccine efficacy against infection and transmission has been established by substantial evidence – mainly influenced by public statements from President Joe Biden, CDC Director Rochelle Walensky, and former Director of the NIAID, Anthony Fauci.

 

But the CAALM petitioners explain that FDA evaluation reports and other documents make it clear that evidence is lacking for such claims.

 

Hence, they’ve requested that the vaccine labels contain “language clarifying that phase III trials were not designed to determine, and failed to provide, substantial evidence of vaccine efficacy against SARS-CoV-2 transmission or death.”

 

The current Pfizer label also doesn’t mention that the phase III randomised trial – following the Dec 2020 emergency authorisation – showed that efficacy declined following an early peak, and therefore should contain “a clear statement that Pfizer vaccine efficacy wanes after 2 months following dose 2.”

 

p1

Anonymous ID: d96317 Feb. 24, 2023, 7:02 p.m. No.18406574   🗄️.is 🔗kun   >>6583 >>6584 >>6604 >>6760 >>6899 >>7039 >>7152 >>7241 >>7263

>>18406571

Further, the FDA issued eight emergency use authorisations for the mRNA vaccines based on “neutralising antibody titres”, a surrogate endpoint. However, the product labels don’t indicate that the surrogate endpoint has not been validated or that it does not accurately reflect the degree of clinical benefit—crucial facts that the CAALM petitioners point out, and that the FDA has acknowledged elsewhere.

 

Updates on safety

The petition highlights the dramatic increase in reports to the FDA’s Vaccine Adverse Event Report System (VAERS) since the roll out of the covid-19 vaccines.

 

In fact, the total number of adverse event reports between 2021 and 2022, far surpass the combined number of adverse event reports in the preceding decade.

 

Notably, many serious adverse events detected in post-marketing surveillance have not been accurately reflected on the vaccine labels.

 

Pulmonary embolism for example, is a potential serious adverse event detected by the FDA’s own post-marketing study. The finding was made between February and April 2021, and as yet, has not been added to Pfizer’s product label.

 

Sudden cardiac death is another adverse event linked to the mRNA vaccines based on autopsy studies from Germany and the US.

 

Neuropathic and autoimmune disorders have also been omitted.

 

Wastila laments the lack of information on the label regarding the potential harm to pregnant and breastfeeding women, or how the injection could impact fertility.

 

“Pregnant women are having the vaccine and not told the mRNA can enter the breast milk, or that the injection can lead to menstrual irregularities. Also, men are not told it has been shown to temporarily decrease sperm concentration,” says Wastila.

 

The labelling doesn’t provide accurate and updated information on the frequency of myocarditis or pericarditis either. The petitioners requested that the labels contain a range of rates that have been reported in the literature, and should stratify estimates by risk factors (notably, age and sex).

 

Currently, the label says “Information is not yet available about potential long-term sequelae” of myocarditis but a study by the CDC has since found that 50% (178/357) of adolescents with post-vaccine myocarditis had >1 symptom lasting 90 days from onset.

 

“Many colleges require all young people to get vaccinated and boosted, but few know about subclinical myocarditis” says Wastila.

 

“I think there could be a lot of young people walking around with no clue that they could be ticking time bombs, that they could have heart damage without symptoms, and no-one is getting them checked because no one is telling them to,” she adds.

 

The reaction to petition

Overall, the reaction to the petition from notable academics and scholars has been positive.

 

Jerome Hoffman, professor of medicine emeritus at UCLA School of Medicine, is not a signatory on the petition, but supports most of the individual points raised by the CAALM petitioners.

 

“Of course the FDA should be honest and include all relevant data (no matter how negative) — but not without putting it in context,” says Hoffman.

 

His primary concern is that highlighting the adverse events should not be done without also emphasising “that best available evidence strongly suggests that the covid vaccines, while certainly imperfect, are enormously beneficial on a population basis.”

 

Hoffman says it’s critical to strike a balance when communicating harms, in a manner that neither increases distrust of science, nor further emboldens vaccine hesitancy.

p2

Anonymous ID: d96317 Feb. 24, 2023, 7:02 p.m. No.18406583   🗄️.is 🔗kun   >>6760 >>6899 >>7039 >>7152 >>7241 >>7263

>>18406574

David Gortler, a pharmacist, pharmacologist and drug safety epidemiologist who worked as an FDA medical reviewer between 2007 and 2011, and senior adviser to the FDA commissioner in 2019-21, was pleased to see the submission.

 

“They're 100% right to bring this up. It's unprecedented in the history of the FDA, that there have been over 13 billion doses of the vaccine given worldwide and neither Pfizer nor Moderna has bothered to keep the label up to date with the latest efficacy and safety findings,” says Gortler. "It should be their number one priority."

 

“The product label is the ultimate authority and owner’s manual for doctors and pharmacists, to go to for the latest, most accurate information about a drug. It’s a living breathing document, that should be regularly updated with the latest epidemiological data,” he adds.

 

Gortler, who is now a fellow at the Ethics and Public Policy Center in Washington DC says, “The FDA can ask for a labelling update, but the truth is, the vaccine manufacturer is the one who ought to maintain updates. However, all vaccine makers have a liability shield, so they are not motivated to update anything.”

 

John Abramson, a physician and lecturer at Harvard Medical School, and author of Sickening: How Big Pharma Broke American Health Care, also supports the CAALM petition to update the vaccine labels to ensure people are able to make informed decisions.

 

“The lack of forthrightness about the underlying clinical trial data - and the lack of coverage of this issue by the mainstream media - are engendering dangerous vaccine skepticism,” says Abramson.

 

“When I went to get a booster from the local pharmacist, I mentioned that there are no data available. The pharmacist replied, ‘We are the data’ – Americans deserve better,” added Abramson.

 

The petition was filed on January 31 and the FDA has 180 days to respond. Members of the public can add comments to the petition HERE.

 

Share

 

This is a reader-supported publication. To support my work, please consider becoming a free or paid subscriber.

 

Give a gift subscription

 

3 of 3

Anonymous ID: d96317 Feb. 24, 2023, 7:02 p.m. No.18406591   🗄️.is 🔗kun   >>6593 >>6760 >>6899 >>7039 >>7152 >>7241 >>7263

https://www.tennessean.com/story/news/politics/2023/02/23/tennessee-legislature-passes-ban-on-gender-affirming-care-for-minors/69935900007/

 

Tennessee legislature passes ban on gender-transition health care for minors

 

Tennessee House Republicans on Thursday overwhelmingly passed a ban on gender-transition health care for minors, which will require transgender children to end their current medical treatment by March 2024.

 

The bill prohibits children from receiving puberty blockers, hormone therapies or surgical procedures.

 

People who received the treatments as minors would also be able to sue parents, guardians and physicians for authorizing the care under a statute of limitations under the legislation. Bill sponsors initially included language to categorize parents seeking such treatments for their kids as abuse or neglect, but that section was later stripped from the bill as it made its way through committees.

 

If it becomes law, the bill would officially take effect this summer and give existing patients until March 31, 2024, to cease treatment, a timeline House Democrats have argued could medically harm patients.

 

The bill will soon be sent to Gov. Bill Lee's desk, which kicks off a 10-day countdown, not including Sundays, for Lee to sign it into law. Even if Lee chooses not to sign, the bill becomes law without his signature unless he vetoes it.

 

Though he rarely takes an explicit position on pending bills, Lee on Friday signaled he is "supportive" of the bill's content.

 

The American Civil Liberties Union plans to sue Tennessee if Lee signs it into law.

 

"All Tennesseans should have access to the healthcare they need to survive and thrive," Lucas Cameron-Vaughn, ACLU-TN staff attorney, said in a statement. "Gender-affirming healthcare for trans youth is safe, necessary, effective and often life-saving. Legislators are risking trans young people’s health, wellbeing and safety with this dangerous legislation. We urge Governor Lee to veto this overreaching, discriminatory bill, or we will see him in court.”

 

House Bill 1 bans minors in Tennessee from accessing gender dysphoria and transition treatments such as puberty blockers and hormone therapies, in addition to surgeries.

 

"These treatments and procedures have a lifetime of negative consequences that are irreversible," bill sponsor Rep. William Lamberth, R-Portland, said.

 

Lamberth has called transition care experimental and dangerous for children. Major U.S. medical associations, such as the American Medical Association and the American Academy of Pediatrics, have supported gender transition health care as evidence-based medicine.

 

The legislation was narrowly tailored to allow the same medications to be used medically elsewhere, as long as they are not used to treat gender dysphoria, while Republicans rebuffed pointed Democratic attempts to block other plastic and reconstructive surgeries that minors can obtain in Tennessee.

 

"It has nothing to do with protecting children from unnecessary medical procedures," Rep. Bo Mitchell, D-Nashville, said. "(Some children) can get their breast enhancements, their nose jobs, that's OK, but these children can't have any medical procedures?"

 

Mitchell said the legislation was unfairly targeting transgender children, and the state would have to answer for it in court.

 

Filed as the first bill of the session following a high-profile controversy that erupted last fall over Vanderbilt University Medical Center offering gender-transition care, the legislation moved quickly through the General Assembly.

p1

Anonymous ID: d96317 Feb. 24, 2023, 7:02 p.m. No.18406593   🗄️.is 🔗kun   >>6760 >>6899 >>7039 >>7152 >>7241 >>7263

>>18406591

 

More:Vanderbilt pauses gender affirmation surgery for minors amid backlash

 

Conservative media personalities and two young women who said they regretted beginning gender transitions as teenagers have testified in support of the bill. Both women received their gender transition care outside of Tennessee.

 

"The vote on the floor today was extremely strong," Lamberth said. "We're going to protect our children, we're going to support our children to mature naturally and give them the love and assistance, mental health treatment, that they need."

 

Multiple Tennessee parents, including at least one whose child will have to stop an ongoing medication regimen, testified against the bill, imploring lawmakers to trust them and their doctors to make the best decisions with their children.

 

The Human Rights Campaign on Thursday urged Lee to veto the bill.

 

“This attempt by radical politicians in Tennessee to ban gender-affirming care is only the latest effort in their war against the LGBTQ+ community, especially against transgender kids," HRC Senior Counsel Cathryn Oakley said. "The state has not only introduced more anti-LGBTQ+ legislation than any other state in this country, but attacks on the fundamental rights of thousands of LGBTQ+ people in Tennessee have been unrelenting for nearly a decade. These extremist lawmakers have intentionally made life harder and more dangerous for trans kids. Gender affirming care is age-appropriate, life-saving, medically necessary care that is only provided after the consent of parents and doctors."

 

Kelly Puente contributed to this report.

2 of 2

Anonymous ID: d96317 Feb. 24, 2023, 7:02 p.m. No.18406621   🗄️.is 🔗kun   >>6760 >>6899 >>7039 >>7152 >>7241 >>7263

Forgotten “Primum Non Nocere” and Increased Mortality after Covid-19 Vaccination

https://www.preprints.org/manuscript/202301.0204/v3

 

Abstract

Background. The main impetus behind the worldwide Covid-19 vaccination campaign in 2021 was to reduce the mortality attributed to SARS-CoV-2 infection in the preceding year. Nevertheless, rigorous analyses of the mortality benefits conferred by this massive vaccination effort have been lacking. Methods Statistics offers us an essential methodological approach for measuring the impacts of Covid-19 vaccination on public health. The mathematical relation between vaccinated-alive groups can be repeated between vaccinated-dead groups with relatively high statistical reliability because of the large population numbers involved. This method also confers greater statistical usefulness because it eliminates the Simpson effect. Results Calculations were performed for each of the following five four-week intervals: weeks 35-38 (2021), weeks 39-42 (2021), weeks 43-46 (2031), weeks 47-50 (2021), and weeks 51(2021)-2(2022). The results obtained confirm that the mortality of the vaccinated coronavirus-infected groups was 14.5% higher on average than the mortality of non-vaccinated coronavirus-infected groups. Conclusions Vaccinated infected groups appear to have higher average mortality than their non-vaccinated infected counterparts. The findings suggest the legitimacy of extending the statistic between vaccinated living and vaccinated dead individuals for different age groups. Calculating the impact of Covid-19 vaccination on the mortality rate is a necessary step toward satisfying the first principle of medicine: “Primum non nocere”, “Do no harm”.